Sana Biotechnology (SANA) PT Lowered to $8 at JMP Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
Tweet
Share
E-mailGet Alerts SANA Hot Sheet
Price: $2.56 --0%
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 6
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 6
Join SI Premium – FREE
JMP Securities analyst Reni Benjamin lowered the price target on Sana Biotechnology (NASDAQ: SANA) to $8.00 (from $9.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- North American Construction Group (NOA:CN) (NOA) PT Lowered to Cdn$20 at BMO Capital
- Element Fleet Management (EFN:CN) (ELEEF) PT Lowered to Cdn$24 at BMO Capital
- Russel Metals Inc. (RUS:CN) (RUSMF) PT Raised to Cdn$95 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
